BMRN BioMarin Pharmaceutical Inc.
$65.68▲ +0.26%
Healthcare
Other
After hours
$65.80▲ +0.18%
Sep 11, 7:30 PM ET
Volume 1.60M
Avg Volume (10D) 1.83M
Key Metrics & Fundamentals
Market Cap
$12.71B
P/E Ratio
177.5
Div Yield
–%
52W Range
49.26 - 70.98
% vs 50 MA
4.01%
% vs 200 MA
13.08%
RSI-14
52.9
MACD Histogram
-0.3400
Beta (1Y vs SPY)
0.42
Free Cash Flow
$133.86M
Gross Rev
$989.71M
Gross Profit
$786.91M
EBITDA
$222.32M
COGS
$202.80M
Operating Exp
$675.94M
Operating Income
$110.97M
EBIT
$110.97M
Pretax Income
$61.38M
Net Income
$44.76M
EPS (Diluted)
0.23
Price & Volume History
Loading chart…
Recent News
BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis
Insider Monkey · Sep 12, 2026 5:02 PM
Growth Without AI: 8 Stock Picks
Barrons.com · Sep 11, 2026 5:00 AM
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence
PR Newswire · Sep 9, 2026 1:05 PM
Achondroplasia Market Analysis Report 2026: Emerging Pipeline Intensifies Competition, Featuring Ascendis Pharma, BioMarin Pharmaceutical, QED Therapeutics (BridgeBio), Novartis, Kyowa Kirin, RIBOMIC
GlobeNewswire · Sep 9, 2026 8:23 AM
3 Reasons to Avoid BMRN and 1 Stock to Buy Instead
StockStory · Sep 8, 2026 1:59 PM
3 Value Stocks We Think Twice About
StockStory · Sep 4, 2026 10:06 PM
BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?
Insider Monkey · Sep 4, 2026 4:26 PM
RARE Stock Crashes In Worst Day Ever — ‘Pharma Bro’ Martin Shkreli Calls It ‘Very Cheap,’ Floats BioMarin Buyout
Stocktwits · Sep 4, 2026 7:24 AM
Ascendis Pharma (ASND) Settles Patent Fight And Wins Canadian Yorvipath Reimbursement Backing
Simply Wall St. · Sep 4, 2026 7:08 AM
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset
Zacks · Sep 3, 2026 4:28 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BMRN's money flow as a full page
Social Sentiment
Avg +0.70 · 3 posts
DDEarningsPriceTarget$BMRN- An Amazing Buying Oppurtunity
r/wallstreetbets · Oct 9, 2025
The post presents BMRN as an 'amazing buying opportunity' based on strong financial growth and future guidance.
very_positive
+0.90
DDEarningsPriceTarget$BMRN Biomarin - The Best Play on the Market?
r/wallstreetbets · Oct 9, 2025
The post presents BMRN as a strong investment opportunity, highlighting significant revenue and income growth projections.
very_positive
+0.90
TradeDDDiscussion20k BMRN YOLO🧪🚀
r/wallstreetbets · Jul 16, 2025
The author expresses optimism about BMRN's future and believes it's undervalued, indicating a positive sentiment.
positive
+0.30
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.